Or Yat Sun's Form 4 filing
Enanta Pharmaceuticals Inc (ENTA) · filed Mar 17, 2023
- Accession no.
- 0001062993-23-007221
- Filed
- Mar 17, 2023
- Trade date
- Mar 15, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $619.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Or Yat SunCIK 0001571212 | Officer (Sr. VP & CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2023 | Common Stock | MOption exerciseAcquired | +13,925 | $14.00 | +$194,950 | 388,627 | Direct | |
| Mar 15, 2023 | Common Stock | SSaleDisposed | −269 | $43.92 | −$11,814.48 | 388,358 | Direct | |
| Mar 15, 2023 | Common Stock | SSaleDisposed | −13,656 | $44.46 | −$607,145.76 | 374,702 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2023 | Common Stock | MOption exerciseDisposed | −13,925 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.